1-7 of 7
Paula M Vertino
Close
Sort by
Journal Articles

Isocitrate Dehydrogenase 2 Mutation Drives Bone Marrow Macrophage Dysfunction without a Complete Block in Hematopoietic Differentiation

Noah Salama, Olivia Lynch, Emily R Quarato, Yuko Kawano, Benjamin Rodems, Eric Cefaloni, Tzu-Chieh Ho, Kathleen E. McGrath, Michael W. Becker, Jane L. Liesveld, Paula M Vertino, James Palis, Jeevisha Bajaj, Laura M. Calvi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9757–9758.
https://doi.org/10.1182/blood-2022-168015
Published: 2022
Journal Articles

Chromatin Accessibility Identifies Regulatory Elements Predictive of Oncogene Expression in Multiple Myeloma

Benjamin G Barwick, PhD, Vikas A. Gupta, MD PhD, Shannon M Matulis, PhD, Jonathan C Patton, B.S., Doris R Powell, MA, Yanyan Gu, MD PhD, David L. Jaye, MD, Karen N Conneely, PhD, Yin C Lin, PhD, Craig C Hofmeister, MDMPH, Ajay Nooka, MDMPH, Jonathan J Keats, PhD, Sagar Lonial, MD FACP, Paula M Vertino, PhD, Larry H. Boise, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-140717
Published: 2020
Journal Articles

Multiple Myeloma Epigenetic Programming Prognostic of Outcome Converges with Loci Reprogrammed in Relapsed/Refractory Disease

Benjamin G Barwick, PhD, Sheri Skerget, PhD, Jonathan J Keats, PhD, Daniel Auclair, Sagar Lonial, Lawrence H. Boise, PhD, Paula M Vertino, PhD, Doris R Powell, MA
Journal: Blood
Blood (2019) 134 (Supplement_1): 858.
https://doi.org/10.1182/blood-2019-124422
Published: 2019
Journal Articles

Whole Genome DNA Methylation Analysis of Commpass Identifies Biomarkers of Multiple Myeloma Survival

Benjamin G Barwick, PhD, Daniel Auclair, PhD, Alex Blanski, Meghan Kirchhoff, Brianne Docter, Daniel C Rohrer, Jonathan J Keats, PhD, Sagar Lonial, MD, Lawrence H. Boise, PhD, Paula M Vertino, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3174.
https://doi.org/10.1182/blood-2018-99-116875
Published: 2018
Journal Articles

Immunoglobulin Lambda Translocations Identify Poor Outcome and IMiD Resistance in Multiple Myeloma and Co-Occur with Hyperdiploidy

Benjamin G Barwick, PhD, Paola Neri, MD, Nizar Bahlis, MD, Ajay K Nooka, MDMPH, Jonathan L Kaufman, MD, Vikas A. Gupta, MD PhD, Daniel Auclair, PhD, Jonathan J Keats, PhD, Sagar Lonial, MD, Paula M Vertino, PhD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 405.
https://doi.org/10.1182/blood-2018-99-113585
Published: 2018
Journal Articles

High-Risk Myeloma Is Demarcated By Immunoglobulin Lambda Light Chain Translocations

Benjamin Barwick, PhD, Vikas A. Gupta, MD PhD, Daniel Auclair, PhD, Jonathan J. Keats, PhD, Sagar Lonial, MD, Paula M Vertino, PhD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1780.
https://doi.org/10.1182/blood.V130.Suppl_1.1780.1780
Published: 2017
Journal Articles

Integrative, Multi-Platform, Whole-Genome Analyses Identify Clinically Relevant Common- and Cell-Specific Signatures in Multiple Myeloma

Jeanne Kowalski, PhD, Khanjan Gandhi, MS, Jeffrey Switchenko, PhD, Yuan Liu, PhD, Sungjin Kim, MS, Gregory Doho, MS, Seung J Kim, Rendong Yang, PhD, Li Chen, MS, Zhaohui Qin, PhD, Scott Newman, PhD, Carlos S Moreno, Ph.D., Paula M Vertino, PhD, Leon Bernal-Mizrachi, M.D., Michael R Rossi, PhD, Sagar Lonial, MD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2012) 120 (21): 3974.
https://doi.org/10.1182/blood.V120.21.3974.3974
Published: 2012